[1]
S. Kumar and N. Kaushik, “Design, Synthesis and Evaluation of Novel Quinoline-Thiazolidinone-Isonicotinamide Hybrids as Potent InhA Inhibitors for Antitubercular Therapy”, ajc, vol. 37, no. 12, pp. 3158–3166, Nov. 2025.